Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2013 Mar;61(3):430-9.
doi: 10.1053/j.ajkd.2012.10.016. Epub 2012 Dec 8.

Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis

Affiliations
Meta-Analysis

Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis

Paweena Susantitaphong et al. Am J Kidney Dis. 2013 Mar.

Abstract

Background: Urinary liver-type fatty acid-binding protein (L-FABP) is a proximal tubular injury candidate biomarker for early detection of acute kidney injury (AKI), with variable performance characteristics depending on clinical settings.

Study design: Meta-analysis of diagnostic test studies assessing the performance of urinary L-FABP in AKI.

Setting & population: Literature search in MEDLINE, EMBASE, Scopus, Google Scholar, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov using search terms "liver-type fatty acid-binding protein" and "L-FABP."

Selection criteria for studies: Studies of humans investigating the performance characteristics of urinary L-FABP for the early diagnosis of AKI and AKI-related outcomes, including dialysis requirement and mortality.

Predictor: Urinary L-FABP.

Outcomes: Diagnosis of AKI, dialysis requirement, and in-hospital death.

Results: 15 prospective cohort and 2 case-control studies were identified. Only 7 cohort studies could be meta-analyzed. The estimated sensitivity of urinary L-FABP level for the diagnosis of AKI was 74.5% (95% CI, 60.4%-84.8%), and specificity was 77.6% (95% CI, 61.5%-88.2%). The estimated sensitivity of urinary L-FABP level for predicting dialysis requirement was 69.1% (95% CI, 34.6%-90.5%), and specificity was 42.7% (95% CI, 3.1%-94.5%); for in-hospital mortality, sensitivity and specificity were 93.2% (95% CI, 66.2%-99.0%) and 78.8% (95% CI, 27.0%-97.4%), respectively.

Limitations: Paucity and low quality of studies, different clinical settings, and variable definitions of AKI.

Conclusions: Although urinary L-FABP may be a promising biomarker for early detection of AKI and prediction of dialysis requirement and in-hospital mortality, its potential value needs to be validated in large studies and across a broader spectrum of clinical settings.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study selection flow diagram.
Figure 2
Figure 2
Hierarchical summary receiver operating characteristic curve displaying the performance of urinary liver-type fatty acid–binding protein for the early diagnosis of acute kidney injury (across all clinical settings).

References

    1. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004 Aug;8(4):R204–212. - PMC - PubMed
    1. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31. - PMC - PubMed
    1. Hsu CY, McCulloch CE, Fan D, Ordonez JD, Chertow GM, Go AS. Community-based incidence of acute renal failure. Kidney Int. 2007 Jul;72(2):208–212. - PMC - PubMed
    1. Hospitalization discharge diagnoses for kidney disease--United States, 1980-2005. MMWR Morb Mortal Wkly Rep. 2008 Mar 28;57(12):309–312. - PubMed
    1. Chertow GM, Soroko SH, Paganini EP, et al. Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney Int. 2006 Sep;70(6):1120–1126. - PubMed

Publication types

MeSH terms

Substances